A Chapter 11 filing by helicopter ambulance operator Air Methods increased the default rate of the Morningstar LSTA US Leveraged Loan Index to 1.36% by amount in October, as rising credit stress from the Healthcare sector continues to drive a majority of payment defaults in the trailing 12-month calculation.
Though trending higher from 0.72% at the end of last year, the rate by amount remains below the 10-year average of 1.86% and historical average of 2.67%.
By issuer count, the default rate is 1.76% for October, up from 1.67% in September, but nearly 30 bps lower than where it stood three months ago.
This brings the lagging 12-month default volume total for index loans to $19.26 billion across 21 issuers at month-end. This compares to $10.73 billion via nine issuers a year ago.
October’s sole default activity among index companies came courtesy of helicopter ambulance operator Air Methods, which filed for Chapter 11 protection on Oct. 24 in the US Bankruptcy Court for the Southern District of Texas.
Interim CEO Jason Kahn in the court declaration pointed to a confluence of factors that led to the filing. In addition to a heavy debt load placed during its 2017 buyout by American Securities, rising interest rates, a tight labor market increasing employee costs, and changes to payor reimbursement dynamics following the 2022 implementation of the No Surprises Act (NSA) rendered its capital structure unsustainable.
The company’s senior secured term loan B due April 2024 had $1.8 billion outstanding, court documents show. Per its restructuring agreement, Air Methods will cut $1.7 billion from its $2.24 billion debt pile. The projected recovery rate for prepetition secured loan claims (excluding the DIP rollup) is 16%, versus 1% for unsecured note claims, according to a disclosure statement filed with the court.
Checkup
The filing by Air Methods marks the fifth index default among companies in the broader Healthcare and Pharmaceutical sector over the last twelve months, accounting for 26% of all LTM issuer defaults in the loan market. By amount, Healthcare (including Pharmaceuticals) has contributed 32% of default volume. KKR-backed GenesisCare and Envision Healthcare also defaulted from the sector this year — similarly citing increasing interest rates and labor shortages — and filed for bankruptcy in June and May, respectively. Pharmaceutical company Mallinckrodt in late August initiated its second trip to bankruptcy court in the space of three years, as it once again seeks to cut debt and resolve litigation with respect to opioid claims.
Looking at sponsor-backed versus non-sponsored companies, the default rate by issuer count among non-sponsored companies in the index in October was nearly unchanged month-over-month at 2.25%, while the default rate for sponsored companies increased to 1.44%, from 1.31% in September.
In forward-looking metrics, the distress ratio, or share of performing loans in the Morningstar LSTA US Leveraged Loan Index priced below 80, rose in October to 5.12% as risk sentiment soured with rate volatility amid deepening conflicts in the Middle East and Ukraine.
LCD data show $71 billion of institutional loans in the index were priced below 80 at the end of October, up from $61 billion in September, but down from a 32-month high of $103 billion at the end of last December. Note, however, that $19 billion of the decline so far this year is from defaulted loans leaving the performing calculation in 2023.
The $71 billion of distressed loans translates to a distress ratio of 5.12%.
Finally, downgrade activity — another forward indicator for potential trouble down the road — continues to outpace upgrades, though at a declining pace. Per LCD data, the rolling three-month ratio of downgrades fell to a 16-month low of 1.60x, from 1.73x in September.
Going forward, with debt interest expenses soaring amid rapidly rising rates and the prospect that this punitive environment has no end in sight, market pros expect the default rate to move above its historical average — and therefore into a default cycle — within the next year. Per LCD’s survey of buyside, sellside and advisory accounts polled in early September, respondents put the 12-month forward forecast for leveraged loan defaults at between 2.5% and 2.99% for the September 2023 rate. At the 2.75% midpoint, this would push the loan default rate slightly above its historical average.
Learn about our editorial standards.